Clinical Trials Browser

Phase 1/2 × Leukemia-Lymphoma, Adult T-Cell × Bortezomib × Clear all

NCT01000285 2017-03-28

ATLL

Phase 1/2 Completed

18 enrolled 13 charts

LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell